10x Genomics (TXG) Short-term Investments (2020 - 2026)

10x Genomics (TXG) has 7 years of Short-term Investments data on file, last reported at $49.6 million in Q1 2026.

• For the quarter ending Q1 2026, Short-term Investments fell 0.56% year-over-year to $49.6 million; the trailing twelve-month figure through Mar 2026 stood at $49.6 million (down 0.56% YoY), and the FY2025 full-year result was $49.4 million, changed 0.22% from the prior year.
• Short-term Investments steadied at $49.6 million in Q1 2026, from $49.4 million in the prior quarter.
• In the past five years, Short-term Investments ranged from a high of $226.8 million in Q1 2022 to a low of $269000.0 in Q2 2024.
• A 5-year average of $55.4 million and a median of $49.4 million in 2024 frame the typical range for Short-term Investments.
• Across the five-year window, Short-term Investments sank 99.33% in 2023 and surged 18319.7% in 2025, its largest moves.
• Tracing TXG's Short-term Investments over 5 years: stood at $2.6 million in 2022, then jumped by 1017.01% to $29.4 million in 2023, then surged by 67.74% to $49.3 million in 2024, then rose by 0.22% to $49.4 million in 2025, then gained by 0.24% to $49.6 million in 2026.
• Business Quant data shows TXG's Short-term Investments at $49.6 million in Q1 2026, $49.4 million in Q4 2025, and $49.6 million in Q3 2025.